Viewing Study NCT02228512

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-03-03 @ 8:32 PM
Study NCT ID: NCT02228512
Status: WITHDRAWN
Last Update Posted: 2018-08-31
First Post: 2014-08-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease View
None Primary Effusion Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HHV8 View
None PEL View
None Immune Modulation View
None CC-4047 View
None IMiD View